Metabolic-associated steatotic liver disease — RACP Written MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Assess and manage metabolic-associated steatotic liver disease fibrosis risk with hepatology referral
Persistent abnormal liver tests with metabolic risk factors and raised liver stiffness suggest clinically significant fibrosis risk, needing structured fibrosis management and specialist input.
Reference: Therapeutic Guidelines: Gastrointestinal; Gastroenterological Society of Australia guidance